Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLONAZEPAM , USP: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

Gender data not available for CLONAZEPAM , USP.

Age Information

The average age of patients reporting adverse events with CLONAZEPAM , USP is 45.7 years.

Geographic Distribution

The majority of adverse event reports for CLONAZEPAM , USP originate from US.

Report Summary & Outcomes

22
Total Reports
22
As Primary/Secondary Suspect
16
Deaths Reported
4
Hospitalizations
1
Life-Threatening

Reporting Timeline

First adverse event report: 20130901. Most recent report: 2014. View full timeline →

More About CLONAZEPAM , USP

CLONAZEPAM , USP Full Profile Reports by Year Drug Interactions